Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Stomach Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fatigue 3 Delirium 3 Chronic Pain 3 Agnosia 3 Uterine Cervical Neoplasms 2

Interventions

Doxorubicin 19 Vincristine 16 Cyclophosphamide 12 Zidovudine 11 Bleomycin 11 Etoposide 10 Rituximab 6 Interferon alpha-2 6 Cytarabine 6 Prednisone 5 Polymerase Chain Reaction 5 Liposomes 5 Dexamethasone 5 Biopsy 5 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Filgrastim 4 tecogalan 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Carmustine 3 interferon alfa-n1 2 fludarabine 2 cabozantinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡